Berkshire Hathaway (BRK.B) Stock Could Be 31% Undervalued Following Its $359B Cash Focus

Berkshire Hathaway has delivered a powerful long term run, and recent headlines around its cash rich insurance arm and possible new AI related deals put a spotlight on a simple question for you as a shareholder: Is the current price really in line with the returns the group earns on the capital it controls?

• Over the past 5 years, Berkshire Hathaway has returned 88.4%, which raises the question of whether the value of its underlying capital returns has kept pace with the share price.
• Insurance operations reportedly holding about US$359b in cash give the conglomerate sizeable firepower, which can support or reshape future returns on invested capital depending on how that cash is deployed and when it is put to work.
• If you'd rather focus on earnings, this one's for you. See why Berkshire Hathaway's 13.6x P/E tells a different valuation story.

For investors, the debate is whether Berkshire Hathaway's current valuation is fully explained by the returns it earns on its existing and future capital base.

If you want a broader watchlist of companies where the story also revolves around capital deployment and quality, a focused screener of 30 high quality undervalued stocks may be useful.

Is Berkshire Hathaway a Bargain on Excess Returns?

The Excess Returns model looks at how efficiently Berkshire Hathaway turns shareholder equity into profits above its cost of capital. Berkshire shows an average return on equity of 11.91%, which the model converts into a stable earnings power of $65,319.23 per share on a book value base of $522,225.90 per share. After charging a cost of equity of $41,042.66 per share, the remaining excess return of $24,276.57 per share is what drives the valuation engine here.

On the model’s numbers, that surplus return is expected to be maintained on a slightly higher stable book value of $548,342.09 per share, based on estimates from two analysts. Because the recent news highlights US$359b of insurance cash and potential AI related deals, the market focus on new capital deployment lines up cleanly with a framework that already assumes Berkshire Hathaway can continue to earn more than its equity cost. The Excess Returns projections put Berkshire Hathaway's estimated intrinsic value substantially above the current share price of $541.96. According to the model, the market is not fully pricing those excess profits at today’s quote. Find out what Berkshire Hathaway could be worth using our Excess Returns estimate.

The Berkshire Hathaway Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Berkshire Hathaway valuation debate leaves off and set out the specific growth, margin and earnings paths that would need to play out for the stock to be worth materially more or less than today’s price on the Community page. Instead of a single output from a ratio or model, they lay out the future that number depends on so you can watch whether that story continues to match reality over time.

A written Narrative on Berkshire Hathaway gives you a clear, number driven view of what has to happen for that US$359b insurance cash pile and any potential AI related equity deals to justify or reshape today’s valuation. It turns loose opinions into specific assumptions on growth, returns on capital and deal outcomes that you can revisit as new results and transaction details arrive over time.

Share your own Narrative for Berkshire Hathaway and set out the assumptions behind your valuation.

One more crucial Berkshire Hathaway question is still unanswered

Berkshire Hathaway's valuation story is only part of the picture, because the research checks have also flagged specific areas of concern that deserve your attention before you get comfortable. Take a closer look at 1 major warning sign before settling on a valuation.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com